Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain.

Journal Information

Full Title: J Crohns Colitis

Abbreviation: J Crohns Colitis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"an infographic plain language summary of this paper is available at: 10 25454/pfizer figshare 21299151"

Code Sharing
Evidence found in paper:

"Conflict of Interest LT has received research funding from AbbVie Canada, Amgen Canada, Gilead Canada, Pfizer Canada, Roche Canada, Sandoz Canada, and Takeda Canada; and has served as an advisory board member for AbbVie Canada, Amgen Canada, Celltrion Canada, JAMP Canada, Janssen Canada, Merck Canada, Pfizer Canada, Roche Canada, Sandoz Canada, and Takeda Canada. MCD reports consulting fees from AbbVie, Arena, Bristol-Myers Squibb, Celgene, Eli Lilly, Galapagos, Gilead, Janssen, Pfizer Inc, Prometheus Labs, Takeda, and UCB; and is a shareholder of Trellus Health. FS has served as an advisory board member for Pfizer Inc; and has received consulting and speaker fees from AbbVie, Amgen, Celltrion, Eurofarma, Ferring Pharmaceuticals, Janssen, Sandoz, Takeda, and UCB. ET, AGB, JCC, SG, and PH are employees and shareholders of Pfizer Inc. JP reports personal fees from AbbVie, Arena, Athos, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Galapagos, Genentech/Roche, GSK, Immunic, Janssen, Mirum, Morphic, Nestlé, Origo, Pandion, Pfizer Inc, Progenity, Revolo, Takeda, Theravance Biopharma, and Wassermann; and has received grant support from AbbVie and Pfizer Inc."

Evidence found in paper:

"Funding These studies were sponsored by Pfizer."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025